Infectious Diseases 903 - Infectious Disease Alert - Mar 01, 2005

Target Audience:

This activity is intended for the infectious disease physician.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford;
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Co-Editor
Joseph F. John, Jr., MD
Chief, Medical Subspecialty Services
Ralph H. Johnson Veterans Administration Medical Center;
Professor of Medicine
Medical University of South Carolina
Charleston, SC

Associate Editors
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases;
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Robert Muder, MD
Hospital Epidemiologist
Pittsburgh VA Medical Center
Pittsburgh
Section Editor, Hospital Epidemiology

Alan D. Tice, MD, FACP
Infections Limited, PS
Tacoma, WA;
Infectious Disease Consultant
John A. Burns School of Medicine
University of Hawaii
Honolulu, HI
Section Editor, Managed Care

Hal B. Jenson, MD, FAAP
Chair
Department of Pediatrics
Director
Center for Pediatric Research
Eastern Virginia Medical School
Children?s Hospital of the King?s Daughters
Norfolk, VA

J. Peter Donnelly, PhD
Clinical Microbiologist
University Hospital Nijmegen
The Netherlands
Section Editor, Microbiology

Jerry D. Smilack, MD
Infectious Disease Consultant
Mayo Clinic Scottsdale
Scottsdale, AZ

Dean L. Winslow, MD, FACP
Chief
Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine
Section Editor, HIV

Authors
Alex Studemeister, MD
Infectious Disease Specialist
San Jose Medical Group
San Jose, California

Subjects:

  • Malaria in Peace and War
  • Corticosteroids in the Treatment of Severe Community-Acquired Pneumonia
  • What a Crab to Diagnose and Monitor Invasive Aspergillosis
  • Antiretroviral Prophylaxis After Nonoccupational Exposure to HIV
  • Case Study: The Clostridial Connection
  • Updates

Objectives:

  • to discuss diagnosis and treatment of infectious diseases
  • present current data regarding use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • present the latest information regarding pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • present prevalence/surveillance data for various diseases, such as AIDS, tuberculosis, malaria, and pneumonia
  • discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapeutic drugs

Financial Disclosure:

In order to reveal any potential bias in this publication, we disclose that Stan Deresinski, MD, FACP serves on the speaker’s bureau of Merck, GlaxoSmithKline, Ortho, Bayer, and Pfizer.

Joseph F. John, Jr., MD is a consultant for Cubist, Roche, and BioMerieux, is on the speaker’s bureau of Merck, Pharmacia, GlaxoSmithKline, Bayer, and Wyeth, and does research for Merck.

Carol A. Kemper, MD, FACP serves on the speaker’s bureau of Virologic, GlaxoSmithKline, Pfizer, and Agouron and is involved in research with Chiron, Merck, Agouron, and Virologic.

Robert Muder, MD does research for Aventis and Pharmacia.

Alan D. Tice, MD, FACP is a consultant for Roche, Merck, and ZLB and is on the speaker’s bureau of Roche, Ortho, GlaxoSmith-Kline, and Pharmacia, and does research for Elan, Roche, Merck, Pharmacia, and Becton-Dickinson.

Hal B. Jenson, MD, FAAP is on the speaker’s bureau of Merck.

J. Peter Donnelly, PhD is a consultant for OrthBioTech and does research for Janssen, Merck, Novartis, Numico, Pharmacia, and Pfizer.

Dean L. Winslow, MD, FACP is a consultant for Bayer Diagnostics and Pfizer/Agouron, and is on the speaker’s bureau for Pfizer/Agouron.

Jerry D. Smilack, MD and Alex Studemeister, MD report no speaker’s bureau, research, stockholder, or consulting relationships having ties to this field of study.

Copyright 2005 AHC Media. All rights reserved.